KI-1003

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKI-1003
Drug Alias Nameeating disorder combination therapeutics (Kuhnil Pharmaceutical)KI-1003
ClassificationSmall molecules
Mechanisms of ActionAppetite modulators
TargetsUpdating
Therapy Area/IndicationsFeeding and Eating Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuhnil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuhnil Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsFeeding and Eating Disorders

Other Information

ATC CodeN/A
Related LinksN/A